405 related articles for article (PubMed ID: 23318281)
21. Driving under the influence of cannabis: a 10-year study of age and gender differences in the concentrations of tetrahydrocannabinol in blood.
Jones AW; Holmgren A; Kugelberg FC
Addiction; 2008 Mar; 103(3):452-61. PubMed ID: 18190663
[TBL] [Abstract][Full Text] [Related]
22. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers.
Vindenes V; Lund HM; Andresen W; Gjerde H; Ikdahl SE; Christophersen AS; Øiestad EL
Forensic Sci Int; 2012 Jun; 219(1-3):165-71. PubMed ID: 22284072
[TBL] [Abstract][Full Text] [Related]
23. A validated method for the detection and quantitation of 50 drugs of abuse and medicinal drugs in oral fluid by gas chromatography-mass spectrometry.
Langel K; Gunnar T; Ariniemi K; Rajamäki O; Lillsunde P
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(13-14):859-70. PubMed ID: 21411382
[TBL] [Abstract][Full Text] [Related]
24. Analysis of tetrahydrocannabinol and its metabolite, 11-nor-Δ⁹-tetrahydrocannabinol-9-carboxylic acid, in oral fluid using liquid chromatography with tandem mass spectrometry.
Coulter C; Garnier M; Moore C
J Anal Toxicol; 2012 Jul; 36(6):413-7. PubMed ID: 22532488
[TBL] [Abstract][Full Text] [Related]
25. Stability of Delta(9)-tetrahydrocannabinol (THC) in oral fluid using the Quantisal collection device.
Moore C; Vincent M; Rana S; Coulter C; Agrawal A; Soares J
Forensic Sci Int; 2006 Dec; 164(2-3):126-30. PubMed ID: 16423482
[TBL] [Abstract][Full Text] [Related]
26. Detection of cannabis use in drivers with the drugwipe device and by GC-MS after Intercept device collection.
Kintz P; Bernhard W; Villain M; Gasser M; Aebi B; Cirimele V
J Anal Toxicol; 2005 Oct; 29(7):724-7. PubMed ID: 16419408
[TBL] [Abstract][Full Text] [Related]
27. Identification and quantification of 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid glucuronide (THC-COOH-glu) in hair by ultra-performance liquid chromatography tandem mass spectrometry as a potential hair biomarker of cannabis use.
Pichini S; Marchei E; Martello S; Gottardi M; Pellegrini M; Svaizer F; Lotti A; Chiarotti M; Pacifici R
Forensic Sci Int; 2015 Apr; 249():47-51. PubMed ID: 25659366
[TBL] [Abstract][Full Text] [Related]
28. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of the Cozart DDS oral fluid collection device.
Speedy T; Baldwin D; Jowett G; Gallina M; Jehanli A
Forensic Sci Int; 2007 Aug; 170(2-3):117-20. PubMed ID: 17624706
[TBL] [Abstract][Full Text] [Related]
30. Determination of Δ9-tetrahydrocannabinolic acid A (Δ9-THCA-A) in whole blood and plasma by LC-MS/MS and application in authentic samples from drivers suspected of driving under the influence of cannabis.
Raikos N; Schmid H; Nussbaumer S; Ambach L; Lanz S; Längin A; König S; Roth N; Auwärter V; Weinmann W
Forensic Sci Int; 2014 Oct; 243():130-6. PubMed ID: 25173986
[TBL] [Abstract][Full Text] [Related]
31. Quantification of six cannabinoids and metabolites in oral fluid by liquid chromatography-tandem mass spectrometry.
Desrosiers NA; Scheidweiler KB; Huestis MA
Drug Test Anal; 2015 Aug; 7(8):684-94. PubMed ID: 25428610
[TBL] [Abstract][Full Text] [Related]
32. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ
J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous analysis of THC and its metabolites in blood using liquid chromatography-tandem mass spectrometry.
Del Mar Ramirez Fernandez M; De Boeck G; Wood M; Lopez-Rivadulla M; Samyn N
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Nov; 875(2):465-70. PubMed ID: 18922747
[TBL] [Abstract][Full Text] [Related]
34. Norwegian roadside survey of alcohol and drug use by drivers (2008-2009).
Gjerde H; Christophersen AS; Normann PT; Assum T; Oiestad EL; Mørland J
Traffic Inj Prev; 2013; 14(5):443-52. PubMed ID: 23697895
[TBL] [Abstract][Full Text] [Related]
35. Development of an electrospray LC-MS/MS method for quantification of Δ(9) -tetrahydrocannabinol and its main metabolite in oral fluid.
Bylda C; Leinenbach A; Thiele R; Kobold U; Volmer DA
Drug Test Anal; 2012; 4(7-8):668-74. PubMed ID: 22374692
[TBL] [Abstract][Full Text] [Related]
36. The recovery of illicit drugs from oral fluid sampling devices.
Dickson S; Park A; Nolan S; Kenworthy S; Nicholson C; Midgley J; Pinfold R; Hampton S
Forensic Sci Int; 2007 Jan; 165(1):78-84. PubMed ID: 16621382
[TBL] [Abstract][Full Text] [Related]
37. Detection of cannabis in oral fluid (saliva) and forehead wipes (sweat) from impaired drivers.
Kintz P; Cirimele V; Ludes B
J Anal Toxicol; 2000 Oct; 24(7):557-61. PubMed ID: 11043659
[TBL] [Abstract][Full Text] [Related]
38. Development of a high-speed MALDI-triple quadrupole mass spectrometric method for the determination of 3,4-methylenedioxymethamphetamine (MDMA) in oral fluid.
Poetzsch M; Steuer AE; Hysek CM; Liechti ME; Kraemer T
Drug Test Anal; 2016 Feb; 8(2):235-40. PubMed ID: 25990956
[TBL] [Abstract][Full Text] [Related]
39. Frequency and irregularity of heart rate in drivers suspected of driving under the influence of cannabis.
Khiabani HZ; Mørland J; Bramness JG
Eur J Intern Med; 2008 Dec; 19(8):608-12. PubMed ID: 19046727
[TBL] [Abstract][Full Text] [Related]
40. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
Davey J; Leal N; Freeman J
Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
